Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.44 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.44 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.44 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.44 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16633834 | 1.00 | EIF2AK2 (0.44) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM | |
| SCHEMBL1914087 | 0.76 | KDM4E (0.50) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM | |
| SCHEMBL1914082 | 0.76 | KDM4E (0.50) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM | |
| SCHEMBL1368017 | 0.76 | HCAR2 (0.48) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM | |
| SCHEMBL1368018 | 0.76 | HCAR2 (0.48) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM | |
| SCHEMBL21001958 | 0.75 | THRB (0.53) | CSNK2A2CSNK2BCSNK2A1P4HTMKDM4E | |
| SCHEMBL5585151 | 0.74 | KDM4E (0.42) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM | |
| SCHEMBL2195182 | 0.73 | NPC1 (0.33) | CYP3A4ALDH1A1RAB9ASMN1; SMN2ESR1 | |
| SCHEMBL2195175 | 0.73 | NPC1 (0.33) | CYP3A4ALDH1A1RAB9ASMN1; SMN2ESR1 | |
| SCHEMBL16634172 | 0.71 | MIF (0.39) | EIF2AK2CSNK2A2CSNK2BCSNK2A1P4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2828243-B1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | SERAGON PHARMACEUTICALS INC (US) | 2018-10-17 | — | — | EP | disclosed |
| US-9499538-B2 | Estrogen receptor modulators and uses thereof | SERAGON PHARMACEUTICALS, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150105403-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | SERAGON PHARMACEUTICALS, INC. | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105403-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | ESR2, ESRRG, GPER1 | EIF2AK2 2429/4885CSNK2A2 788/4885CSNK2B 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.